Antiphospholipid Antibodies and Endothelial Cells

Hughes Grv. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.

Meroni PL , Tincani A. , Harris EN et al. The pathophysiology of antiphospholipid antibodies. Clin Exp Rheumatol 1989; 7(Suppl. 3): 81-4.

Khamashta MA , Asherson RA , Hughes Gvr. Possible mechanisms of action of the antiphospholipid binding antibodies. Clin Exp Rheumatol 1989 ; 7(Suppl. 3): 84-9.

Alarcon-Segovia D. The pathophysiology of anti-phospholipid antibodies . Semin Clin Immunol 1991; 1: 11-19.

Triplett DA Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol 1992; 28: 211-15.

Carreras LO , Defreyn G. , Machin SJ et al. Arterial thrombosis, intrauterine death and 'lupus' anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; i: 244-6.

Carreras LO , Vermylen JG Lupus anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb Haemos 1982 ;48:38-40.

Vermylen J. , Amout J. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes? J Lab Clin Med 1992; 120: 10-12.

Vismara A. , Meroni PL , Tincani A. et al. Relationship between anticardiolipin and anti-endothelial antibodies in SLE. Clin Exp Immunol 1988; 74: 247-53.

Hasselaar P. , Derksen Rhw , Blokzijl L. , de Groot PG. Cross-reactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 1990; 63: 169-73.

McGrae KR , de Michele A. , Samuels P. et al. Detection of endothelial cell reactive immunoglobulin in patients with antiphospholipid antibodies. Br J Haematol 1991; 79: 595-605.

Cervera R. , Khamashta MA , Font J. et al. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 1991; 11: 1-6.

Del Papa N. , Meroni PL , Tincani A. et al. Relationship between antiphospholipid and anti-endothelial antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 1992; 10: 37-42.

Del Papa N. , Comforti G. , Gambini D. et al. Characterization of antiendothelial cell antibodies in antiphospholipid syndrome. In: Molecular Basis of Human Diseases. Polli EE (ed.), Amsterdam, London, New York, Tokyo, Excerpta Medica, 1993: 67-74.

Zwaal Rfa , Hemker HC Blood cell membranes and haemostasis. Haemostasis 1982; 11: 12-39.

Del Papa N. , Conforti G. , Gambini L. et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994; 70: 211-16.

Bevers EM , Galli M. Cofactors involved in the antiphospholipid syndrome. Lupus 1992; 1: 51-3.

McNeil HP , Simpson RJ , Chesterman CN , Krilis SA Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (Papolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4210-4.

Galli M. , Comfurius P. , Maasen C. et al. Anticardiolipin antibodies (aCL) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990 ; 335: 1544-7.

Allegri F. , Balestrieri G. , Cattaneo R. et al. The plasma cofactor and anticardiolipin antibodies. Clin Exp Rheumatol 1990; 8: 613-14.

Matsuura E. , Igarashi Y. , Fujimoto M. , Ichikawa K. , Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease . Lancet 1990; i: 177-8.

Shousboe I. Binding of β2-glycoprotein I to platelets: effect of adenlytate cyclase activity. Thromb Res 19890; 19: 225-37.

La Rosa L. , Meroni PL , Tincani A. et al. Beta-2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994 (in press).

Arvieux J. , Roussel B. , Jacob MC , Colomb MG Measurement of antiphospholipid antibodies by ELISA using β-glycoprotein I as antigen. J Immunol Method 1991; 143: 223-9.

Viard JP , Amoura Z. , Bach JF Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.

Cabral AR , Rodriguez M. , Cabiedes J. , Alarcon-Segovia D. Antibodies to β2-glycoprotein I associate with antiphospholipid syndrome whether primary (PAPS) or secondary to systemic lupus erythematosus . Arthritis Rheum 1993; 6(Suppl.): S242 (abstract).